News about Global Pharma

UltraSight Partners with Mayo Clinic to Advance Next Generation Cardiac Care with AI

UltraSight is collaborating with Mayo Clinic on a new endeavor with the goal of enhancing cardiac care by harnessing the power of AI in point-of-care ultrasound.

Global Pharma | 04/06/2024 | By Manvi |  546

PhoreMost Join Hands with Boehringer Ingelheim

PhoreMost Ltd. has made a multi-project target discovery collaboration with Boehringer Ingelheim.

Global Pharma | 04/06/2024 | By Aishwarya |  560

Rhythm Pharma Presents Patient-Reported Experiences with Hyperphagia at ENDO 2024

Rhythm Pharmaceuticals, Inc. has presented the first patient and caregiver reported experiences from qualitative interviews following the completion of a Phase 2 trial.

Global Pharma | 04/06/2024 | By Aishwarya |  510

Pulsenmore Appoints Len Farris as Chief Commercial Officer

Farris will lead Pulsenmore's global commercial growth, overseeing sales, business development, and partnerships.

Global Pharma | 03/06/2024 | By Manvi |  533

Formosa Laboratories Acquires Synchem to Expand in North America

Formosa Laboratories, Inc. has completed its acquisition of SynChem, Inc., a contract research laboratory located in suburban Chicago.

Global Pharma | 03/06/2024 | By Aishwarya |  788

ASPA Organizes Global Meet at Drupa 24 for Authentication and Traceability Professionals

The Authentication Solution Providers' Association (ASPA) has made its entry into the Middle East and Africa regions with the introduction of its MEA (Middle East & Africa) Chapter.

Global Pharma | 03/06/2024 | By Aishwarya |  943

DefiniGEN and Atelerix to Ship In Vitro Cell Models Internationally

DefiniGEN Ltd. and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to a top-tier pharma customer in the US.

Global Pharma | 03/06/2024 | By Aishwarya |  219

Parse Biosciences Unveils Trailmaker Data Analysis Platform

Parse Biosciences has introduced Trailmaker, its user-friendly cloud platform purpose-built for single cell data analysis.

Global Pharma | 03/06/2024 | By Aishwarya |  382

Rgenta Therapeutics Presents Preclinical Data at ASCO 2024

Rgenta Therapeutics has showcased its preclinical data at ASCO 2024 from its lead program, RGT-61159, which is being developed for the potential treatment of adenoid cystic carcinoma (ACC), colorectal cancer (CRC) and other solid tumors as well as acute myeloid leukemia (AML).

Global Pharma | 01/06/2024 | By Aishwarya |  840

Catalyst Oncology and Imerman Angels Announce Collaboration

Catalyst Oncology, the biotech-focused oncology CRO brand of Catalyst Clinical Research, will start a collaboration with Imerman Angels, a renowned nonprofit organization providing free, personalized one-on-one cancer support.

Global Pharma | 31/05/2024 | By Manvi |  456